These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5969513)

  • 21. Cortisol suppression index: a new approach to interpreting the DST in depression.
    Bernstein JP; Chung SY; Avila KS
    J Clin Psychiatry; 1982 Dec; 43(12):476-8. PubMed ID: 7161249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dexamethasone suppression test: identification of subtypes of depression.
    Schatzberg AF; Rothschild AJ; Stahl JB; Bond TC; Rosenbaum AH; Lofgren SB; MacLaughlin RA; Sullivan MA; Cole JO
    Am J Psychiatry; 1983 Jan; 140(1):88-91. PubMed ID: 6847992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormonal profile of depressed patients].
    Lavretskaia EF; Tenidieva VD; Lavretskaia GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(4):555-8. PubMed ID: 3591135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin and cortisol "switches" during mania, depression, and euthymia in a drug-free bipolar patient.
    Kennedy SH; Tighe S; McVey G; Brown GM
    J Nerv Ment Dis; 1989 May; 177(5):300-3. PubMed ID: 2708973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures.
    Mazer AK; Cleare AJ; Young AH; Juruena MF
    Behav Brain Res; 2019 Jan; 357-358():48-56. PubMed ID: 29702176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in hormonal indicators during the treatment of depression of different types].
    Krasnov VI; Kokhanenko EM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):101-5. PubMed ID: 2750367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-dexamethasone plasma cortisol levels in depressive patients receiving electro-convulsive therapy.
    Varma SL; Lal N; Trivedi JK; Anand M
    Indian J Med Res; 1988 Jan; 87():86-91. PubMed ID: 3360488
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolic syndrome and cortisol/DHEAS ratio in patients with bipolar disorder and schizophrenia.
    Vuksan-Ćusa B; Sagud M; Mihaljević-Peleš A; Jakšić N; Jakovljević M
    Psychiatr Danub; 2014 Jun; 26(2):187-9. PubMed ID: 24909257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The level and circadian rhythm of plasma tryptophan, tyrosine and cortisol in manic-depressive patients and its clinical significances (author's transl)].
    Kishimoto H
    Seishin Shinkeigaku Zasshi; 1977 Aug; 79(8):375-92. PubMed ID: 601112
    [No Abstract]   [Full Text] [Related]  

  • 30. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression.
    Claustrat B; Chazot G; Brun J; Jordan D; Sassolas G
    Biol Psychiatry; 1984 Aug; 19(8):1215-28. PubMed ID: 6498244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age and sex on cortisol secretion in depressives and normals.
    Halbreich U; Asnis GM; Zumoff B; Nathan RS; Shindledecker R
    Psychiatry Res; 1984 Nov; 13(3):221-9. PubMed ID: 6597461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dexamethasone suppression test in mixed bipolar disorder.
    Evans DL; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):615-7. PubMed ID: 6846594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Decrease in transcortin binding activity in depression].
    Ktiouet J; de Luca HS; Zouaghi H; Toure-Saw H; Benkelfat C; Loo H
    Encephale; 1984; 10(5):215-6. PubMed ID: 6519016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness.
    Linkowski P; Mendlewicz J; Leclercq R; Brasseur M; Hubain P; Golstein J; Copinschi G; Van Cauter E
    J Clin Endocrinol Metab; 1985 Sep; 61(3):429-38. PubMed ID: 2991318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania.
    Meltzer HY; Uberkoman-Wiita B; Robertson A; Tricou BJ; Lowy M
    Life Sci; 1983 Dec; 33(25):2541-9. PubMed ID: 6645813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of variations in physiological cortisol levels on thyrotropin secretion in subjects with adrenal insufficiency: a clinical research center study.
    Samuels MH
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1388-93. PubMed ID: 10770171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder.
    Gallagher P; Watson S; Smith MS; Young AH; Ferrier IN
    Schizophr Res; 2007 Feb; 90(1-3):258-65. PubMed ID: 17222537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to dexamethasone in affective disorder outpatients.
    Steardo L; Cardone G; Casiello M; Sorge F; Muscettola G
    Acta Psychiatr Belg; 1984; 84(3):218-27. PubMed ID: 6485840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups.
    Mendlewicz J; Charles G; Franckson JM
    Br J Psychiatry; 1982 Nov; 141():464-70. PubMed ID: 7150882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers of depression in cancer patients.
    Jehn CF; Kuehnhardt D; Bartholomae A; Pfeiffer S; Krebs M; Regierer AC; Schmid P; Possinger K; Flath BC
    Cancer; 2006 Dec; 107(11):2723-9. PubMed ID: 17036362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.